Shots: Dewpoint to receive up to $305M as up front and milestone along with royalties on sales of any approved product emerges under the collaboration The collaboration leverages Dewpoint’s biomolecular […]readmore
Tags : Exclusive Agreement
Shots: VALBIOTIS to receive ~$5.1M up front, ~$67.7 as development & commercial milestones and royalties on sales of therapy. Nestle to get exclusive global rights to commercialize TOTUM-63 in the […]readmore
Shots: Sanofi will lead FDA negotiations for the OTC switch, marketing and distribution of Tamiflu OTC and will be responsible for clinical programs and fund all studies needed to support […]readmore